|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-4-2
|
|
pubmed:abstractText |
The purpose of this study was to evaluate integrated (18)F-FDG PET/CT in patients with idiopathic pulmonary fibrosis (IPF) and diffuse parenchymal lung disease (DPLD).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
538-45
|
|
pubmed:meshHeading |
pubmed-meshheading:19289428-Aged,
pubmed-meshheading:19289428-Diagnosis, Differential,
pubmed-meshheading:19289428-Fluorodeoxyglucose F18,
pubmed-meshheading:19289428-Humans,
pubmed-meshheading:19289428-Lung Diseases, Interstitial,
pubmed-meshheading:19289428-Male,
pubmed-meshheading:19289428-Pilot Projects,
pubmed-meshheading:19289428-Positron-Emission Tomography,
pubmed-meshheading:19289428-Pulmonary Fibrosis,
pubmed-meshheading:19289428-Radiopharmaceuticals,
pubmed-meshheading:19289428-Reproducibility of Results,
pubmed-meshheading:19289428-Sensitivity and Specificity,
pubmed-meshheading:19289428-Subtraction Technique
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
|
|
pubmed:affiliation |
Institute of Nuclear Medicine, University College London, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
